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Pi for the rats treated with calcitonin was 2.46 t 0.27 pmol/ml.
Co., St. Louis, MO). Both diet and water were given ad This value was significantly less than that of 3.88 & 0.32 pmol/ libitum. ml (P < 0.05) for the control animals but was significantly greater than the maximum transport of Pi of 1.16 t 0.05 pmol/ On the morning of the experiments, the rats were ml (P < 0.05) for the rats treated with PTH. Furthermore, anesthetized with an intraperitoneal injection of Inactin there was no significant difference between the maximum (100 mg/kg body wt) (Byk-Gulden Konstanz, Hamburg, transport of Pi for the rats treated with PTH and that of 1.04 West Germany) and then placed on a heated table where t 0.05 pmol/ml for the rats treated with PTH plus calcitonin. a rectal probe was inserted to monitor body temperature. We conclude that pharmacologic doses of calcitonin decrease A midline incision was made through the skin on the the tubular capacity for Pi reabsorption of the kidney and that ventral surface of the neck and thyroparathyroidectomy the effect is significantly smaller than that of maximally phos-(TPTX) was performed using thermocautery. Subsephaturic doses of PTH.
quently, a tracheotomy and intubation of the trachea with PE-240 tubing were performed in order to maintain parathyroid hormone; thyroparat hyroidectomy; maximum a clear airway and to allow the animals to breathe spontransport Of Pi taneously. Catheters were then placed in jugular veins (PE-50) for infusions, in the carotid artery (PE-50) for monitoring blood pressure and the sampling of blood, CALCITONIN, WHICH IS A POTENT hypophosphatemic and in the bladder (PE-100) for urine collections. agent, has been reported to have a marked phosphaturic Following TPTX, a 2-h recovery period was allowed effect in the rat by some investigators (4, 5, 15) but not for the attainment of a steady state. Thirty minutes after by others (11, 14, 17, 18) . Part of the controversy is the start of the recovery period, three separate infusions perhaps related to the difficulty in dissociating the hy-were started, each at a rate of 2 ml/h. One infusion was pophosphatemic from the direct effects of the hormone 6% inulin, the second was 0.9% saline, and the third was on the kidney. Oberleithner et al. (13) attempted to one of four treatment solutions, each of which designates circumvent the systemic effects of calcitonin by dripping one of the four protocols used in this study. The descripthe hormone on superficial proximal tubules. They found tion of each solution is as follows. Solution 1 was 0.9% that calcitonin was phosphaturic and, furthermore, that saline; solution 2 contained calcitonin (Calcimar, salmon the phosphaturic effect of calcitonin was additive to the calcitonin, Armour Pharmaceutical Co., Kankakee, IL) phosphaturic effect of parathyroid hormone (PTH). Miland was designed to deliver the hormone at 1 U* kg-'. haud and Moukhtar (12) and Anast et al. (l) , on the min-'; solution 3 contained PTH (synthetic, l-34, Beckother hand, reported that calcitonin and PTH did not man Instruments, Palo Alto, CA) and was designed to have an additive effect on the excretion of phosphate deliver a maximal phosphaturic dose of 1 U l kg-' l rein-'; (Pi) at the level of the whole kidney.
and solution 4 contained PTH plus calcitonin and was In the present study, graded infusions of phosphate designed to deliver both hormones at a rate of 1 U. kg-l. were used to control for hypophosphatemia and to determin-'. After the recovery period, a 20-min control clearmine the effects of pharmacologic doses of calcitonin on ance period was taken. Then the saline infusion, used in the tubular capacity of Pi transport of the kidney in the all four groups, was replaced with successive Pi solutions presence and absence of PTH. Thus, it was possible to formulated to deliver Pi at the rates of 1, 2, and 3 pmol/ 31.6 t 2.8%, and UpiV of 1.72 t 0.31 pmol/min for the group given PTH were, however, significantly different from the corresponding values for the group given calcitonin and the group given saline. Finally, there was no significant difference in Reabpi, FEpi, or UpiV between the group given PTH and the group given PTH plus calcitonin. Inulin and Pi concentrations in the plasma and urine were determined by the anthrone (10) and Chen (7) methods, respectively. Calcium concentrations were determined by atomic absorption spectrometry, and sodium concentrations were measured by flame photometry.
All values are *expressed as means t SE. Statistical comparisons between means were first made by one-way analysis of variance followed by multiple comparison testing using Tukey's method.
RESULTS
During the control clearance period for the group given saline, the absolute reabsorption of Pi (Reabpi) was 6.93 t 0.39 pmol/min, the fractional excretion of Pi (FEpi) was 1.1 t 0.3%, and the absolute excretion of Pi (U,iV) was 0.08 t 0.02 pmol/min (Table 1) . These values were not significantly different from those of the group given calcitonin. The Reabpi of 1.16 t 0.05 pmol/min, FEp, of Values for plasma Pi were plotted against normalized values of reabsorption of Pi per glomerular filtration rate (ReabpJGFR) in order to construct curves indicating the maximum transport of Pi (TmpJGFR) for each of the four treatments used in this study (Fig. 1) . The maximum transport of Pi for the group given saline was 3.88 t 0.32 pmol/ml, which was significantly greater than that for the group given calcitonin (2.46 t 0.27 pmol/ml). For the group given PTH, the maximum transport of Pi of 1.16 or 0.05 pmol/ml was significantly less than that for both the group given calcitonin and the group given saline but was not significantly different from the value of 1.04 t 0.05 for the group given PTH plus calcitonin.
Plasma Pi in the group receiving saline was 2.52 t 0.17 mM during the control clearance period. The values for plasma Pi for the groups given calcitonin, PTH, and PTH plus calcitonin were all lower than that for the group given saline, with the lowest value being 1.49 t 0.04 mM, which was for the group given PTH plus calcitonin. The infusions of Pi resulted in increases in plasma Pi in all groups, with the greatest changes seen during the last infusion of Pi (3 pmol/min).
The greatest change was seen in the group given saline (A = 2.13 mM), while the smallest change was detected in the group given PTH plus calcitonin (A = 0.61 mM). At base line, plasma Ca was below 1.90 mM for all groups, indicating the efficacy of TPTX. With successive infusions of Pi, plasma Ca decreased in all groups.
During the experiments, blood pressure fell slightly in each group, particularly toward the end of the experiments. However, all valu .es were well within the range for normal renal function (X00 mmHg).
Glomerular filtration rate (GFR) remained relatively constant throughout
the experiments in all groups. In the group given calcitonin, GFR was slightly higher than in the other groups, but again was within the normal range.
Fractional excretion of Na (FEN,) was greater in the group given calcitonin than in the group given PTH and the group given saline. The most pronounced natriuresis was found in the group given PTH plus calcitonin.
DISCUSSION
The hypophosphatemic effect of calcitonin is well documented (2, 19, 20, 21) and is consistent with the findings of the present study. Phosphate infusions were used to differentiate the hypophosphatemic effect from the direct effect of calcitonin on the renal handling of Pi and to determine the capacity for reabsorption of Pi (8, 9) . The results of the present study show that with increasing rates of infusion of Pi, calcitonin causes a greater increase in both the absolute and fractional excretion of Pi compared with controls. In addition, when Reabp./ GFR is evaluated as a function of plasma Pi, calcitonin significantly decreased the capacity for tubular reabsorption of Pi (Fig. 1) responses were noted in the same study. The nature of the discrepancies in results between these studies is not clear, although in the present study it is apparent that when the fall in plasma Pi is corrected there is a definite inhibitory effect of calcitonin on the tubular transport of Pi.
As was expected, PTH caused a significant increase in the FEr, and Up.V, consistent with findings from other studies (4, 5) . The inhibitory effect of PTH on Pi transport was also reflected by the low maximum transport of Pi, which was similar to that reported by Frick et al. (9) .
The issue as to whether calcitonin has an additive effect to the phosphaturic effect of PTH was addressed recently by Oberleithner et al. (13) . With the intent to avoid the systemic effects of calcitonin, they compared the effects of PTH and calcitonin applied topically to superficial proximal tubules microinfused with 33P-labeled Pi in the presence of a systemic infusion of PTH. Their results showed that a greater amount of 33P-labeled Pi was recovered in the urine with the application of calcitonin than with the application of PTH, and therefore they concluded that calcitonin had an additive phosphaturic effect to PTH. In the present study, however, there was no significant difference between the maximum transport of Pi for PTH and that for PTH plus calcitonin, which indicates that at the whole kidney level calcitonin does not have an additive effect to maximally phosphaturic doses of PTH on the inhibition of maximal rates of Pi transport. On the other hand, the phosphaturic effect of PTH was additive to calcitonin. This result does not rule out additivity of effects at physiologic levels of the two hormones.
It has been previously shown that calcitonin is natriuretic in the rat (3, 16) . In the present study, a mild natriuresis was detected in rats treated with calcitonin, but the greatest natriuretic response was found in rats treated with PTH plus calcitonin.
This suggests that PTH may enhance the natriuretic effect of calcitonin.
Based on the findings of the present study, we conclude that pharmacologic doses of both calcitonin and PTH decrease the tubular capacity for Pi reabsorption, with calcitonin having a less potent effect. Moreover, calcitonin does not have an additive effect to a maximal phosphaturic dose of PTH in decreasing the tubular transport of Pi for the kidney. 
